What is Voyager Therapeutics, Inc. Common Stock's Market Cap?

Voyager Therapeutics, Inc. Common Stock's Market Cap is $209.5M, based on as-reported figures from SEC (XBRL) filings.

What is Voyager Therapeutics, Inc. Common Stock's Enterprise Value?

Voyager Therapeutics, Inc. Common Stock's Enterprise Value is $93.2M, based on as-reported figures from SEC (XBRL) filings.

What is Voyager Therapeutics, Inc. Common Stock's Price / Sales?

Voyager Therapeutics, Inc. Common Stock's Price / Sales is 6.1×, based on as-reported figures from SEC (XBRL) filings.

What is Voyager Therapeutics, Inc. Common Stock's EV / Revenue?

Voyager Therapeutics, Inc. Common Stock's EV / Revenue is 2.7×, based on as-reported figures from SEC (XBRL) filings.

What is Voyager Therapeutics, Inc. Common Stock's EV / EBITDA?

Voyager Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Voyager Therapeutics, Inc. Common Stock's Revenue (TTM)?

Voyager Therapeutics, Inc. Common Stock's Revenue (TTM) is $34.5M, based on as-reported figures from SEC (XBRL) filings.

What is Voyager Therapeutics, Inc. Common Stock's Net Income (TTM)?

Voyager Therapeutics, Inc. Common Stock's Net Income (TTM) is -$107.7M, based on as-reported figures from SEC (XBRL) filings.

What is Voyager Therapeutics, Inc. Common Stock's EBITDA?

Voyager Therapeutics, Inc. Common Stock's EBITDA is -$113.4M, based on as-reported figures from SEC (XBRL) filings.

What is Voyager Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Voyager Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.75, based on as-reported figures from SEC (XBRL) filings.

What is Voyager Therapeutics, Inc. Common Stock's EBITDA Margin?

Voyager Therapeutics, Inc. Common Stock's EBITDA Margin is -329.0%, based on as-reported figures from SEC (XBRL) filings.

Voyager Therapeutics, Inc. Common Stock (VYGR) Financial Statements

Voyager Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG005ZSY242

XNAS · usd

3.40▼ 0.11 (-3.13%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close3.51

Day's Range3.38 – 3.50

52-Week Range2.94 – 5.55

Volume488.0K

Avg Volume449.2K

Share Statistics

Shares Outstanding

Employees141

ExchangeXNAS

Listed2015-11-11

Share count as of July 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Voyager Therapeutics, Inc. Common Stock (VYGR)

What is Voyager Therapeutics, Inc. Common Stock's Market Cap?: Voyager Therapeutics, Inc. Common Stock's Market Cap is $209.5M, based on as-reported figures from SEC (XBRL) filings.
What is Voyager Therapeutics, Inc. Common Stock's Enterprise Value?: Voyager Therapeutics, Inc. Common Stock's Enterprise Value is $93.2M, based on as-reported figures from SEC (XBRL) filings.
What is Voyager Therapeutics, Inc. Common Stock's Price / Sales?: Voyager Therapeutics, Inc. Common Stock's Price / Sales is 6.1×, based on as-reported figures from SEC (XBRL) filings.
What is Voyager Therapeutics, Inc. Common Stock's EV / Revenue?: Voyager Therapeutics, Inc. Common Stock's EV / Revenue is 2.7×, based on as-reported figures from SEC (XBRL) filings.
What is Voyager Therapeutics, Inc. Common Stock's EV / EBITDA?: Voyager Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Voyager Therapeutics, Inc. Common Stock's Revenue (TTM)?: Voyager Therapeutics, Inc. Common Stock's Revenue (TTM) is $34.5M, based on as-reported figures from SEC (XBRL) filings.
What is Voyager Therapeutics, Inc. Common Stock's Net Income (TTM)?: Voyager Therapeutics, Inc. Common Stock's Net Income (TTM) is -$107.7M, based on as-reported figures from SEC (XBRL) filings.
What is Voyager Therapeutics, Inc. Common Stock's EBITDA?: Voyager Therapeutics, Inc. Common Stock's EBITDA is -$113.4M, based on as-reported figures from SEC (XBRL) filings.
What is Voyager Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Voyager Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.75, based on as-reported figures from SEC (XBRL) filings.
What is Voyager Therapeutics, Inc. Common Stock's EBITDA Margin?: Voyager Therapeutics, Inc. Common Stock's EBITDA Margin is -329.0%, based on as-reported figures from SEC (XBRL) filings.